Quantcast
Information About Cancer And Oncology That Everyone Should

Information About Cancer And Oncology That Everyone Should Know

Rayshell Clapper for redOrbit.com - Your Universe Online Cancer is a real concern for many people. The concern may come from a genetic predisposition, environmental triggers, or simply the health-conscious need to have a better understanding of...

Latest Cancer treatments Stories

2014-10-31 23:04:18

The Mesothelioma Applied Research Foundation is optimistic about results reported by AduroBioTech, Inc. of their Phase 1b clinical trial of CRs-207, a novel immunotherapy agent. Alexandria, VA (PRWEB) October 31, 2014 The interim results, which were reported during the International Mesothelioma Interest Group’s meeting last week by Raffit Hassan, MD, a researcher at the National Cancer Institute (NCI) and former chair of the Meso Foundation’s Science Advisory Board, were promising....

2014-10-30 12:29:56

HOUSTON, Oct. 30, 2014 /PRNewswire-USNewswire/ -- Improved surgical outcomes for ovarian cancer, expanded potential impact for new drugs, and a novel family outreach program to head off cancers fueled by known genetic risk mutations are among the early innovations of The University of Texas MD Anderson Cancer Center's Moon Shots Program. First-of-a-kind combination clinical trials; advanced molecular analysis to guide treatment and screening; and a focused program to gather, store, access...

2014-10-30 08:33:52

LOS ANGELES, Oct. 30, 2014 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced an upcoming presentation highlighting its novel technology and its lead drug candidate, aldoxorubicin. The presentation, titled, "Drug Conjugates Bind Covalently to Albumin: A New Approach," will be given by Sant P. Chawla, M.D., F.R.A.C.P., Director of the Sarcoma Oncology Center and principal investigator of the...

2014-10-23 12:29:06

CARMEL, Ind., Oct. 23, 2014 /PRNewswire/ -- Sylvia Rosenberg was 27 when she found a lump in her right breast. A biopsy confirmed she had early stage breast cancer. Her doctor recommended a lumpectomy followed by chemotherapy and hormone therapy. Sylvia had watched her aunt battle breast cancer, and she was determined to find a better treatment. Her research confirmed that SonoPhoto Dynamic Therapy (SPDT) combined with hyperthermia had a better success rate than conventional...

2014-10-23 08:37:02

LUGANO, Switzerland, October 23, 2014 /PRNewswire/ -- ~ At a dose of 20 mug/kg, Palonosetron, administered as a singledose, is as effective as ondansetron 0.15 mg/kg given three times a day to a maximum dose of 32mg ~ No safety concerns were raised by the study Helsinn Group, the company focused on building quality cancer care, presented data at the International Society of Paediatric Oncology (SIOP) congress establishing that palonosetron, at a dose 20 mug/kg, is a...

2014-10-16 23:03:38

Lawrence Livermore biomedical researcher Mike Malfatti is working with two researchers at the University of California, Davis, Comprehensive Cancer Center to leverage dramatic advances in biological accelerator mass spectrometry (AMS) to see how cancer patients respond to the chemotherapeutic drug carboplatin. Livermore, California (PRWEB) October 16, 2014 Buoyed by several dramatic advances, Lawrence Livermore National Laboratory scientists think they can tackle biological science in a...

2014-10-15 12:32:29

LONDON, Oct. 15. 30, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018. This report provides:An overview of the global market for cancer immunotherapiesAnalyses of global market trends, with data from 2012, estimates for 2013, and projections of...

2014-10-14 08:33:18

SAN RAFAEL, Calif., Oct. 14, 2014 /PRNewswire/ -- Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation microinvasive diagnostics, devices and drug delivery technologies, announced today that US Patent No. 8,834,544 has issued to the Company. Photo - http://photos.prnewswire.com/prnh/20141013/151744 Logo - http://photos.prnewswire.com/prnh/20141013/151743LOGO The patent, entitled "Photodynamic Therapy for Tumors...

2014-10-09 08:27:59

DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct. 9, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research:...

2014-10-07 08:28:48

University of Mannheim Medical Center is first site opened TORONTO and CHICAGO, Oct. 7, 2014 /PRNewswire/ - Pinnacle Biologics, Inc. ("Pinnacle"), a subsidiary of Concordia Healthcare Corp., ("Concordia") (TSX: CXR) (OTCQX: CHEHF), announced today the initiation of the pivotal Phase 3 trial (OPUS) in Germany for a rare form of bile duct cancer for which there is currently no acceptable therapy. OPUS is an Open-label, multicenter phase 3 on the efficacy and safety of Photodynamic...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.